Celldex Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 30.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.36B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company’s drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias,...